COPT Defense Properties (NYSE:CDP) Sets New 52-Week High – Time to Buy?

COPT Defense Properties (NYSE:CDP) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $32.78 and last traded at $32.4350, with a volume of 27824 shares changing hands. The stock had previously closed at $32.39.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Wells Fargo & Company upped their target price on shares of COPT Defense Properties from $30.00 to $33.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Truist Financial boosted their price objective on COPT Defense Properties from $30.00 to $31.00 and gave the stock a “hold” rating in a report on Monday, December 15th. Weiss Ratings restated a “buy (b-)” rating on shares of COPT Defense Properties in a report on Wednesday, January 21st. Citigroup lifted their target price on COPT Defense Properties from $29.00 to $34.00 and gave the company a “neutral” rating in a research report on Tuesday. Finally, Evercore ISI reissued an “outperform” rating on shares of COPT Defense Properties in a research report on Friday, February 6th. Six analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, COPT Defense Properties has an average rating of “Moderate Buy” and a consensus target price of $33.63.

COPT Defense Properties Trading Down 1.1%

The company has a quick ratio of 2.34, a current ratio of 3.95 and a debt-to-equity ratio of 1.77. The firm has a market cap of $3.63 billion, a P/E ratio of 23.79 and a beta of 0.86. The firm’s 50-day simple moving average is $29.65 and its 200 day simple moving average is $29.18.

COPT Defense Properties (NYSE:CDP) last issued its quarterly earnings results on Thursday, February 5th. The company reported $0.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.68 by $0.02. COPT Defense Properties had a net margin of 19.94% and a return on equity of 9.82%. The company had revenue of $197.36 million during the quarter, compared to analyst estimates of $188.79 million. During the same quarter last year, the business posted $0.65 EPS. COPT Defense Properties’s quarterly revenue was up 7.6% compared to the same quarter last year. COPT Defense Properties has set its FY 2026 guidance at 2.710-2.790 EPS and its Q1 2026 guidance at 0.670-0.690 EPS. As a group, analysts expect that COPT Defense Properties will post 2.67 earnings per share for the current year.

Institutional Investors Weigh In On COPT Defense Properties

Large investors have recently added to or reduced their stakes in the company. Campbell & CO Investment Adviser LLC raised its stake in COPT Defense Properties by 9.7% in the 4th quarter. Campbell & CO Investment Adviser LLC now owns 37,030 shares of the company’s stock valued at $1,029,000 after acquiring an additional 3,266 shares during the period. Swiss National Bank increased its stake in shares of COPT Defense Properties by 1.8% in the fourth quarter. Swiss National Bank now owns 222,700 shares of the company’s stock worth $6,191,000 after purchasing an additional 3,900 shares in the last quarter. Metis Global Partners LLC raised its position in shares of COPT Defense Properties by 5.2% in the fourth quarter. Metis Global Partners LLC now owns 26,725 shares of the company’s stock valued at $743,000 after purchasing an additional 1,326 shares during the period. Deutsche Bank AG lifted its stake in shares of COPT Defense Properties by 1.8% during the 4th quarter. Deutsche Bank AG now owns 148,732 shares of the company’s stock valued at $4,135,000 after buying an additional 2,646 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in COPT Defense Properties by 8.3% in the 4th quarter. JPMorgan Chase & Co. now owns 3,862,294 shares of the company’s stock worth $107,372,000 after buying an additional 296,221 shares during the period.

COPT Defense Properties Company Profile

COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.